|
2024
|
Invention
|
Composition for treating il-6-related diseases.
The present invention provides a pharmaceutical ... |
|
|
Invention
|
High concentration antibody-containing liquid formulation.
The problem to be solved is to provid... |
|
|
Invention
|
Method for preparing aromatic amino acid derivative.
The present invention provides methods of e... |
|
|
Invention
|
Cyclic peptide compound having kras inhibitory action.
The present inventors found cyclic peptid... |
|
|
Invention
|
Compositions comprising antigen-binding molecules.
The present invention relates to pharmaceutic... |
|
|
Invention
|
Polypeptide modification method for purifying polypeptide multimers.
The present invention provi... |
|
|
Invention
|
Crystal of nitrogen-containing heterocyclic compound having nrf2 activation effect. The present i... |
|
|
Invention
|
Multi-specific antigen-binding molecule having alternative function to function of blood coagulat... |
|
|
Invention
|
Pharmaceutical composition for use in prevention and/or treatment of disease that develops or pro... |
|
|
Invention
|
Anti-nr10 antibody and use thereof.
The present inventors successfully obtained anti-NR10 antibo... |
|
|
Invention
|
Pharmaceutical composition comprising non-ionic surfactants.
The present invention relates to a ... |
|
|
Invention
|
Methods and compositions for treating cancer. The invention provides methods and compositions for... |
|
|
Invention
|
Antibody molecules.
The present invention provides pharmaceutical compositions comprising second... |
|
|
Invention
|
Treatment of thyroid eye disease with satralizumab. All currently available treatment options for... |
|
|
Invention
|
Method for producing amide group-containing compound using n-carboxyamino acid anhydride. This me... |
|
|
Invention
|
Method for producing cyclic peptide compound. As a method for cyclization when producing a cyclic... |
|
|
Invention
|
Composition containing cyclic peptide compound and surfactant. 1123456101011163978888999911166 al... |
|
|
Invention
|
Method for stabilizing protein-containing pharmaceutical preparation. The present invention provi... |
|
|
Invention
|
Method for screening molecules of interest capable of forming complexes with plurality of types o... |
|
|
Invention
|
Biomarker for predicting prognosis in sepsis patient and use thereof. The present invention provi... |
|
|
Invention
|
Method for producing eutectic of cyclic peptide. This method for producing a eutectic containing ... |
|
|
Invention
|
Conditionally activated receptor signaling by using scaffold protein. The present invention relat... |
|
|
Invention
|
Anti-hla-dq2.5/8 antibody and its use for the treatment of celiac disease.
The invention provide... |
|
|
Invention
|
Cytotoxicity-inducing therapeutic agent.
Disclosed are bispecific antibodies with heavy chain co... |
|
|
Invention
|
Nitrogen-containing heterocyclic compound having myt1 inhibitory activity. 46104A4HA56HAHA); and ... |
|
|
Invention
|
Filling nozzle.
The present invention provides a filling nozzle obtained by using a resin select... |
|
|
Invention
|
Anti-latent tgf-beta 1 antibodies and methods of use.
An objective of the invention is to provid... |
|
|
Invention
|
Anti-latent tgf-beta 1 antibodies and methods of use. An objective of the invention is to provide... |
|
|
P/S
|
Pharmaceutical preparations. Providing education and training services in the medical
field. Pro... |
|
|
Invention
|
Protease-activated cytokine.
The present invention relates to fusion proteins or protein complex... |
|
2023
|
Invention
|
Cross-species anti-latent tgf-beta 1 antibodies and methods of use.
The present invention provid... |
|
|
Invention
|
Method for screening for molecules of interest capable of forming complexes with plurality of tar... |
|
|
Invention
|
Cell culture plan creation device and cell culture system. In a cell culture plan creation device... |
|
|
Invention
|
Work instruction device. In the present invention, a robot system (100) includes: mobile manipula... |
|
|
Invention
|
Novel therapeutic agent for septicemia, and a method for screening for same.
The present inventi... |
|
|
Invention
|
Antigen-binding molecule promoting disappearance of antigens having plurality of biological activ... |
|
|
Invention
|
Therapeutic agent for cancer of patient with decrease in rb1 function using myt1 inhibitor and ch... |
|
|
Invention
|
Method for screening molecules of interest capable of forming complexes with plurality of target ... |
|
2022
|
Invention
|
Drug formulation of anti-hla-dq2.5 antibody.
The present invention relates to anti-HLA-DQ2.5 ant... |
|
|
Invention
|
Method for preparing prefilled syringe formulation.
An object of the present invention is to red... |
|
|
Invention
|
Compound having photocleavable moiety, conjugate, and screening method using same.
The present i... |
|
|
Invention
|
Cytotoxicity-inducing therapeutic agent for use in treatment of cancer.
The present disclosure p... |
|
|
Invention
|
Uses of dll3-targeting multispecific antigen-binding molecules.
The disclosure provides uses of ... |
|
|
Invention
|
Method for producing arylamide derivative.
The present disclosure provides, for example, a metho... |
|
|
Invention
|
Protease-mediated target specific cytokine delivery using fusion polypeptide.
The present invent... |
|
|
Invention
|
Formulation containing dihydropyridazine-3,5-dione derivative (as amended).
The present inventio... |
|
|
Invention
|
Preparation containing cyclic peptide compound and method for producing same.
The present invent... |
|
|
Invention
|
Anti-c1s antibody.
The present invention provides antibodies that comprises an antigen-binding r... |
|
2021
|
P/S
|
Pharmaceutical preparations. |
|
|
Invention
|
Prefilled syringe formulation with needle with needle shield containing novel modified antibody. ... |
|
|
P/S
|
Pharmaceutical preparations for human use, namely, pharmaceutical antibodies or its fragments or ... |
|
|
P/S
|
Pharmaceutical research and development services and providing information about medical and scie... |
|
2020
|
P/S
|
Pharmaceuticals consisting of antibodies or its fragments or
its derivatives, cells or genes tha... |
|
2019
|
P/S
|
Pharmaceutical research and development services and
providing information about medical and sci... |
|
|
P/S
|
Pharmaceuticals consisting of antibodies or its fragments or
its derivatives; cells or genes tha... |
|
2017
|
P/S
|
Providing educational classes, seminars, workshops, symposiums and conferences and training servi... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of neuromyelitis optica spectrum disorder |
|
2015
|
P/S
|
Pharmaceutical preparations for the treatment of hemophilia A. |
|
|
P/S
|
[ Pharmaceutical oncology preparations ] Providing educational classes, seminars, workshops, symp... |
|
|
P/S
|
pharmaceutical preparations for the treatment of Hemophilia A |
|
2013
|
P/S
|
pharmaceutical preparation, namely, an anti-cancer drug |
|
2012
|
P/S
|
Injection devices for medical purposes. |
|
|
P/S
|
injection devices for medical purposes |
